MedPath

Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT)

Not Applicable
Completed
Conditions
Obesity; Familial
Registration Number
NCT04579263
Lead Sponsor
Federal Research and Clinical Center of Physical-Chemical Medicine
Brief Summary

Search for mechanisms of the effect of fecal microbiota transplantation on patients with obesity

Detailed Description

1. To select recipients of fecal samples according to eligibility criteria;

2. To perform fecal microbiota transplantation for patients with obesity;

3. To analyze the efficacy of fecal microbiota transplantation for patients with obesity within six months after therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
2
Inclusion Criteria
  • age of patients - from 18 to 75 years, both sexes;
  • patients with obesity (body mass index ≥40
  • patient's informed consent to perform fecal microbiota transplantation
Exclusion Criteria
  • presence of a concomitant chronic infectious disease or malignancy
  • patients with a proven allergy to foods not excluded from the donor's diet
  • absence of the patient for one or more intermediate stages of the examination.
  • informed refusal to continue therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in insulin sensitivity within FMT, 6 months after FMT]6 months after FMT

participants will undergo euglycaemic glucose clamp study

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Endocrinology Research Centre, Moscow

🇷🇺

Moscow, Russian Federation

Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow (FRCC PCM)

🇷🇺

Moscow, Russian Federation

Endocrinology Research Centre, Moscow
🇷🇺Moscow, Russian Federation

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.